1. AB0259 The high basal level antibodies to modified citrullinated vimentin (anti-MCV) – predictive factor of response to tocilizumab therapy in rheumatoid arthritis. (23rd January 2014) Authors: Avdeeva, A.S.; Alexandrova, E.N.; Novikov, A.A.; Panasyuk, E.Y.; Cherkasova, M.V.; Nasonov, E.L. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0370 Association of Clinical Efficacy with Serum Level of Adalimumab (ADA) and Anti- Adalimumab Antibody Levels in Patients with Early Rheumatoid Arthritis (RA). (10th June 2014) Authors: Avdeeva, A.S.; Aleksandrova, E.N.; Novikov, A.A.; Karateev, D.E.; Luchihina, E.L.; Cherkasova, M.V.; Nasonov, E.L. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA). (23rd January 2014) Authors: Avdeeva, A.S.; Alexandrova, E.N.; Panasyuk, E.Y.; Lukina, G.V.; Nasonov, E.L. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0218 Association of Matrix Metalloproteinase-3 Level with Clinical Efficacy of Subcutaneous Methotrexate in Dmard -Naive Patients with Early Rheumatoid Arthritis. (9th June 2015) Authors: Avdeeva, A.S.; Aleksandrova, E.N.; Karateev, D.E.; Luchikhina, E.L.; Smirnov, A.V.; Novikov, A.A.; Cherkasova, M.V.; Nasonov, E.L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0110 The Effect of Subcutaneous (SC) Methotrexate (MTX) and Adalimumab (ADA) on Cytokine Profile in MTX-Naive Patients with Early Rheumatoid Arthritis (RA). (10th June 2014) Authors: Avdeeva, A.S.; Novikov, A.A.; Aleksandrova, E.N.; Karateev, D.E.; Luchihina, E.L.; Nasonov, E.L. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗